Device Trial Radar · NCT07248930
Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns
Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Oct 1, 2025
Primary completion
Dec 31, 2026
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Efferon JSCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 25, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 1 year, up to 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This observational pilot study aims to identify criteria for evaluating the effectiveness of hemoadsorption with the Efferon LPS NEO device in pediatric burn injury. Participants will be prospectively assigned to the treatment group and compared with a retrospectively selected control group. Each patient in the treatment group will undergo two hemoadsorption sessions, each lasting 6-12 hours, with an interval of 24-120 hours between procedures. The sessions may be performed in combination with hemofiltration or hemodiafiltration at the discretion of the investigator.
Conditions
- Burns
Interventions
Efferon LPS NEODevice
Efferon LPS NEO, a medical device, which is a cylindrical body filled with a polymeric hemosorbent that selectively absorbs LPS and excess cytokines. Two hemoadsorption procedures will be performed per patient, with a duration of 6-12 hours each and an interval of 24-120 hours between procedures. The procedures may be administered in combination with hemofiltration or hemodiafiltration, as determined by the investigator.
Primary outcomes
What the sponsor says the trial is designed to measure.
- ICU length of stayTime frame: 1-28 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Children's City Clinical Hospital No. 9 named after G.N. Speransky of the Moscow City Health Department
Moscow, Russia
Children's municipal multi-specialty clinical center of high medical technology
Saint Petersburg, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.